Short paper

Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study

Tarig B Higazi¹, Amy D Klion², Michel Boussinesq³ and Thomas R Unnasch¹

¹  Division of Geographic Medicine, University of Alabama at Birmingham, Birmingham, AL USA

²  Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD USA

³  Institut de Recherche pour le Developpement, Departement Societes et Sante, Paris, France

Filaria Journal 2004, 3:4doi:10.1186/1475-2883-3-4

Published:	29 June 2004

Abstract

Ivermectin (or Mectizan™) is widely used by onchocerciasis and lymphatic filariasis control programs worldwide. Generally, Mectizan™ is both safe and well tolerated. An exception to this general pattern is in some areas co-endemic for Onchocerca volvulus and Loa loa, where a number of severe adverse reactions to Mectizan™ have been noted in L. loa infected individuals. The vast majority of these severe adverse events have occurred in Southern Cameroon. This suggested the hypothesis that the parasites endemic to Southern Cameroon might form a distinct population that exhibited a phenotype of eliciting severe adverse reactions in Loa-infected individuals upon Mectizan™ exposure. To test this hypothesis, the DNA sequences of three potentially polymorphic loci were compared among L. loa parasites from Southern Cameroon and other endemic foci in Sub-Saharan Africa. Analysis of these data suggested that parasites from Southern Cameroon were at least as genetically diverse as those from other foci. Furthermore, no polymorphisms were noted that were unique to and shared among the parasite isolates from Southern Cameroon. Although a limited number of parasite isolates were tested, these results do not appear to support the hypothesis that L. loa parasites from Southern Cameroon represent a unique, genetically isolated population.